Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01627535 : Feasibility of Intraoperative Optical Imaging and Spectroscopy in Brain Tumors
PhaseN/A
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Neurosurgical patient population in the City of Hope brain and spinal tumor
neurosurgical programs that have been diagnosed with a brain tumor.

- Only lucid patients qualified to consent to neurosurgical procedure will be
approached for participation in this study.

- We do intend to enroll subjects with potentially terminal brain tumors. Due to the
potential benefit of intraoperative mapping, we are not planning to exclude these
subjects.

- Patients with any type of brain tumor will be eligible for participation.

- All subjects must have the ability to understand and the willingness to sign a
written informed consent.

Exclusion Criteria:

- There are no exclusion criteria except for individuals without a brain tumor and the
location of the craniotomy. If the exposed area of brain is not compatible with
peripheral stimuli or volitional activity the subject cannot be enrolled.

- Subjects, who in the opinion of the investigator, may not be able to comply with the
safety monitoring requirements of the study.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01627535      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740